On December 19, Eastern Time, Moderna options saw a total of 122203 contracts traded, with calls accounting for 59% and puts making up 40%.
Moderna has 1074467 contracts outstanding, with calls accounting for 56% and puts making up 43%.
The top volume gainer was the 35 dollars Call option expiring on December 26, 2025, with 2943 contracts traded.
On the news front, Based on recent key news:

1. Dec 19, Moderna announced CEPI's investment of up to $54.3 million to advance its H5 pandemic influenza vaccine candidate to licensure, boosting investor confidence and driving the stock up 9%.

2. Dec 20, U.S. health policy changes under Kennedy, including reduced funding for mRNA vaccines, created uncertainty in the sector, impacting Moderna's stock volatility.

3. Dec 22, broader market trends in biotech and healthcare sectors influenced by macroeconomic factors and policy shifts contributed to the stock's movement.Biotech sector sees increased volatility.
Please note: The chart below does not include options expiring within five days.
<img src="https://assets.lbctrl.com/h5hub/optrank/images/2025-12-22/ST_US_MRNA_en.png" alt="image" original-src="https://assets.lbctrl.com/h5hub/optrank/images/2025-12-22/ST_US_MRNA_en.png"/>

MRNA

On December 19, Eastern Time, Moderna options saw a total of 122203 contracts traded, with calls accounting for 59% and puts making up 40%.

Trending | MRNA Surges 9% last Friday, Some Call options Soar 800%